Details of the Drug
General Information of Drug (ID: DMFCMPS)
Drug Name |
Daidzin
|
|||||
---|---|---|---|---|---|---|
Synonyms |
AC1N4RYA; MLS000563445; SCHEMBL3423674; CHEMBL115316; KYQZWONCHDNPDP-UHFFFAOYSA-N; HMS3604G15; HMS3348J07; HMS2194K16; AKOS024284500; AC-6036; MCULE-3802707688; SMR000232339; ST077114; SR-01000721602; SR-01000721602-3; I06-0227; 3-(4-hydroxyphenyl)-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one; 4H-1-Benzopyran-4-one, 7-(.beta.-D-glucopyranosyloxy)-3-(4-hydroxyphenyl)-; 3-(4-hydroxyphenyl)-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4H-chromen-4-one
|
|||||
Drug Type |
Small molecular drug
|
|||||
Structure | ||||||
3D MOL | 2D MOL | |||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 416.4 | ||||
Logarithm of the Partition Coefficient (xlogp) | 0.7 | |||||
Rotatable Bond Count (rotbonds) | 4 | |||||
Hydrogen Bond Donor Count (hbonddonor) | 5 | |||||
Hydrogen Bond Acceptor Count (hbondacc) | 9 | |||||
Chemical Identifiers |
|
|||||
Cross-matching ID | ||||||
Combinatorial Drugs (CBD) | Click to Jump to the Detailed CBD Information of This Drug | |||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
|||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Drug Off-Target (DOT) |
|
|||||||||||||||||||||||||||||||
Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||||||||